Master Regulator Genes of Asthma Identified

Master regulator genes of asthma have been identified by researchers. It provides a new path forward in the study of asthma and the development of novel therapies.

After identifying nasal gene signatures for mild, moderate, and severe persistent asthma, the researchers applied probabilistic causal methods to identify master regulator genes and validated their results in independent cohorts.

‘Nasal signatures of mild, moderate, and severe asthma have been identified. Master regulator genes that causally regulate key biological processes such as inflammatory response and ciliary function that underlie asthma have also been identified. Potential to develop novel therapeutics for asthma.’

Researchers identified :

1. Master regulator gene common to asthma across severity and ages (FOXJ1)
2. Master regulator genes of severe persistent asthma in children (LRRC23, TMEM231, CAPS, PTPRC FYB)
3. Master regulator genes of mild/moderate persistent asthma in children and adults (C1orf38, FMNL1).

The identified master regulators causally regulate the expression of downstream genes that modulate ciliary function and inflammatory response to influence asthma.

Method

156 children were recruited at Mount Sinai Health System in New York with severe persistent asthma as well as controls for nasal transcriptome profiling.

Network-based and probabilistic causal methods were applied to identify severe asthma genes and their master regulators.

The same approach was then taken in an independent cohort of 190 adults with mild/moderate asthma and controls to identify mild/moderate asthma genes and their master regulators.

Comparative analysis of the master regulator genes followed by validation testing in independent children with severe asthma (n=21) and mild/moderate asthma (n=154) was then performed.

Said Mount Sinai's Dr. Supinda Bunyavanich of the research: "Asthma is a common disease that affects people of all ages around the world. We studied nasal samples from children and adults with varying asthma severity not only to identify nasal signatures of mild, moderate, and severe asthma, but also to decipher master regulator genes that causally regulate key biological processes such as inflammatory response and ciliary function that underlie asthma. The master regulators we identified provide a novel path forward for uncovering mechanisms and novel therapy for asthma."



Source: Eurekalert